cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells indroplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.

Health Care

Biotechnology

CYTENA

Julian Riba

Edmund Yap

Yafees Sarwar

Andreas H.

Martin K.

Lena Lautscham

John Carroll

Fernando Aprile García

Dominik Bernhardt

The Leadership Team at CYTENA is responsible for setting the strategic direction of the company and driving its vision to innovate in the field of single-cell technologies. Comprising key executives including the CEO and COO, the team focuses on operational excellence, financial performance, and market expansion, ensuring that the cy-Clone device and its applications in drug development and genetic analysis lead the industry. They also foster collaboration across departments to enhance product development and customer support, while navigating the complexities of the biosciences landscape globally.

Leadership Team

Operations and Project Management

Sales and Marketing

Leadership Team

About

Team members

Other teams at CYTENA

Operations and Project Management

Sales and Marketing